Preprint Article Version 2 This version is not peer-reviewed

Radiogenomics Pilot Study: Association Between Radiomics and SNP-Based Microarray Copy Number Variation in Diagnosing Renal Oncocytoma and Chromophobe Renal Cell Carcinoma

Version 1 : Received: 21 October 2024 / Approved: 21 October 2024 / Online: 22 October 2024 (09:15:44 CEST)
Version 2 : Received: 24 October 2024 / Approved: 24 October 2024 / Online: 25 October 2024 (10:24:10 CEST)

How to cite: Alhussaini, A. J.; Veluchamy, A.; Kernohan, N.; Palmer, C. N. A.; Steele, J. D.; Nabi, G. Radiogenomics Pilot Study: Association Between Radiomics and SNP-Based Microarray Copy Number Variation in Diagnosing Renal Oncocytoma and Chromophobe Renal Cell Carcinoma. Preprints 2024, 2024101596. https://doi.org/10.20944/preprints202410.1596.v2 Alhussaini, A. J.; Veluchamy, A.; Kernohan, N.; Palmer, C. N. A.; Steele, J. D.; Nabi, G. Radiogenomics Pilot Study: Association Between Radiomics and SNP-Based Microarray Copy Number Variation in Diagnosing Renal Oncocytoma and Chromophobe Renal Cell Carcinoma. Preprints 2024, 2024101596. https://doi.org/10.20944/preprints202410.1596.v2

Abstract

Background: RO and ChRCC are kidney tumours with overlapping characteristics, making differentiation between them challenging. Objectives: The objective of this research is to create a radiogenomics map by correlating radiomic features to molecular phenotypes in ChRCC and RO, using resection as the gold standard. Methods: Fourteen patients (6 RO and 8 ChRCC) were included in the study. A total of 1,875 radiomic features were extracted from CT scans, alongside 632 cytobands containing 16,303 genes from the genomic data. Results: Feature selection algorithms applied to the radiomic features resulted in 13 key features. From the genomic data, 24 cytobands highly correlated with histology were selected and cross-correlated with the radiomic features. The analysis identified four radiomic features that were strongly associated with seven genomic features. Conclusion: These findings demonstrate the potential of integrating radiomic and genomic data to enhance the differential diagnosis of RO and ChRCC, paving the way for more precise and non-invasive diagnostic tools in clinical practice.

Keywords

chromophobe; oncocytoma; radiogenomics; computed tomography; renal masses

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.